Facile one-pot synthesis and in silico study of new heterocyclic scaffolds with 4-pyridyl moiety: Mechanistic insights and X-ray crystallographic elucidation
Fathy M. Abdelrazek,
Magdi E.A. Zaki,
Sami A. Al-Hussain,
Basant Farag,
Ali M. Hebishy,
Mohamed S. Abdelfattah,
Safaa M. Hassan,
Ahmed F. El-Farargy,
Lyuba Iovkova,
David Mross,
Sobhi M. Gomha
Affiliations
Fathy M. Abdelrazek
Chemistry Department, Faculty of Science, Cairo University, Giza, 12613, Egypt
Magdi E.A. Zaki
Department of Chemistry, Faculty of Science, Imam Mohammed Ibn Saud Islamic University (IMSIU), Riyadh, 11623, Saudi Arabia
Sami A. Al-Hussain
Department of Chemistry, Faculty of Science, Imam Mohammed Ibn Saud Islamic University (IMSIU), Riyadh, 11623, Saudi Arabia
Basant Farag
Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt
Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt; Fakultät für Chemie und Chemische Biologie, TU Dortmund, Dortmund, 44227, Germany
Lyuba Iovkova
Fakultät für Chemie und Chemische Biologie, TU Dortmund, Dortmund, 44227, Germany
David Mross
Fakultät für Chemie und Chemische Biologie, TU Dortmund, Dortmund, 44227, Germany
Sobhi M. Gomha
Department of Chemistry, Faculty of Science, Islamic University of Madinah, Madinah, 42351, Saudi Arabia; Corresponding author.
4-Acetylpyridine 1 and malononitrile 2 were allowed to react in a 3MCRs with dimedone 3a or cyclohexa-1,3-dione 3b under reflux to afford 4-methyl-4-(pyridin-4-yl)-5,6,7,8-tetrahydro-4H-chromene derivatives 4a,b respectively. The mechanism of the reaction has been studied and the structures elucidated by analytical, spectral as well as X-ray crystallographic data. Heterocyclic compounds find widespread application in pharmaceutical and agrochemical products. Docking analyses were performed on the synthesized compounds to assess their binding modes with various amino acids of the target protein tubulin (PDB Code - 1SA0). The results indicated promising binding scores for compounds 4a and 4b, suggesting a strong affinity for the tubulin binding site. Finally, ADMET for the synthesized compounds 4a, 4b, 5, 8a and 8b were carried out. The drug likeness and pharmacokinetic properties of the prepared compounds were also evaluated. Notably, all of the novel compounds adhered to Lipinski's rule (Ro5) without any violations.